Marinus Pharmaceuticals reported $30.9M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Amgen AMGN:US $ 3.74B 804M
Aptinyx Inc APTX:US $ 19.38M 207K
Biogen BIIB:US $ 1921.1M 225.6M
Eisai 4523:JP Y 211704M 22380M
Enanta Pharmaceuticals ENTA:US $ 52.56M 5.49M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Gilead Sciences GILD:US $ 6393M 89M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Intra Cellular Therapies ITCI:US $ 107.66M 4.02M
Marinus Pharmaceuticals MRNS:US $ 30.9M 2.26M
Minerva Neurosciences NERV:US $ 7.99M 13.39M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Supernus Pharmaceuticals SUPN:US $ 150.54M 2.41M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
YTE INCY:US $ 616.69M 135.42M